BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23940122)

  • 41. A study of Clostridium difficile-associated disease at King Chulalongkorn Memorial Hospital, Thailand.
    Pupaibool J; Khantipong M; Suankratay C
    J Med Assoc Thai; 2008 Jan; 91(1):37-43. PubMed ID: 18386542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clostridium difficile is no longer just a nosocomial infection or an infection of adults.
    Pituch H
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S42-5. PubMed ID: 19303569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011.
    Magee G; Strauss ME; Thomas SM; Brown H; Baumer D; Broderick KC
    Am J Infect Control; 2015 Nov; 43(11):1148-53. PubMed ID: 26521932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
    Pakyz AL; Jawahar R; Wang Q; Harpe SE
    J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quinolone use as a risk factor for nosocomial Clostridium difficile-associated diarrhea.
    Yip C; Loeb M; Salama S; Moss L; Olde J
    Infect Control Hosp Epidemiol; 2001 Sep; 22(9):572-5. PubMed ID: 11732787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of interventions to reduce the incidence of Clostridium difficile infection at a London teaching hospital trust, 2003-2011.
    Marufu O; Desai N; Aldred D; Brown T; Eltringham I
    J Hosp Infect; 2015 Jan; 89(1):38-45. PubMed ID: 25480022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clostridium difficile infections: do we know the real dimensions of the problem?
    Tattevin P; Buffet-Bataillon S; Donnio PY; Revest M; Michelet C
    Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S36-40. PubMed ID: 23664578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea.
    Raveh D; Rabinowitz B; Breuer GS; Rudensky B; Yinnon AM
    Int J Antimicrob Agents; 2006 Sep; 28(3):231-7. PubMed ID: 16908119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of a clinical prediction scale for hospital-onset Clostridium difficile infection.
    Chandra S; Thapa R; Marur S; Jani N
    J Clin Gastroenterol; 2014; 48(5):419-22. PubMed ID: 24172178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clostridium difficile infection: a Serbian single-center experience.
    Korac M; Milosevic I; Markovic M; Popovic N; Ilic M; Markovic A; Nikolic J; Jevtovic D
    J Infect Dev Ctries; 2015 Feb; 9(2):136-40. PubMed ID: 25699487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Case-controlled review of Clostridium difficile-associated diarrhoea in southern Tasmania.
    Halim HA; Peterson GM; Friesen WT; Ott AK
    J Clin Pharm Ther; 1997; 22(5-6):391-7. PubMed ID: 19160724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.
    DuPont HL; Garey K; Caeiro JP; Jiang ZD
    Curr Opin Infect Dis; 2008 Oct; 21(5):500-7. PubMed ID: 18725800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.
    Aldeyab MA; Kearney MP; Scott MG; Aldiab MA; Alahmadi YM; Darwish Elhajji FW; Magee FA; McElnay JC
    J Antimicrob Chemother; 2012 Dec; 67(12):2988-96. PubMed ID: 22899806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control.
    Lai KK; Melvin ZS; Menard MJ; Kotilainen HR; Baker S
    Infect Control Hosp Epidemiol; 1997 Sep; 18(9):628-32. PubMed ID: 9309434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens.
    Husain A; Aptaker L; Spriggs DR; Barakat RR
    Gynecol Oncol; 1998 Oct; 71(1):104-7. PubMed ID: 9784328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology of community-onset Clostridium difficile infection in a community in the South of England.
    Fellmeth G; Yarlagadda S; Iyer S
    J Infect Public Health; 2010; 3(3):118-23. PubMed ID: 20869672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.
    Marwick CA; Yu N; Lockhart MC; McGuigan CC; Wiuff C; Davey PG; Donnan PT
    J Antimicrob Chemother; 2013 Dec; 68(12):2927-33. PubMed ID: 23825381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is Clostridium difficile infection a particular problem after reversal of ileostomy?
    Randall JK; Young BC; Patel G; Fitzgerald A; George BD
    Colorectal Dis; 2011 Mar; 13(3):308-11. PubMed ID: 19925492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corticosteroid use is associated with a reduced incidence of Clostridium difficile-associated diarrhea: a retrospective cohort study.
    Wojciechowski AL; Parameswaran GI; Mattappallil A; Mergenhagen KA
    Anaerobe; 2014 Dec; 30():27-9. PubMed ID: 25108272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Diarrhea associated with Clostridium difficile: one-year experience in a general hospital].
    Bouza E; Padilla B; Catalán P; Sánchez-Carrillo C; Blázquez R; Peláez T
    Rev Clin Esp; 1996 Jul; 196(7):424-30. PubMed ID: 8804202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.